RegCell Announces Two Peer-Reviewed Publications Supporting its Robust Scientific Foundation on Antigen-Specific Tolerance to Treat Autoimmune Diseases

Scientists rehabilitate disease-causing T cells into tolerance builders

Science Spotlight: Autoimmune Treg therapy from Nobel Prize winner Sakaguchi

In 2 papers, Nobel winner debuts technique to turn rogue T cells into their own treatment

Viewpoint: Japan is on the cusp of a tech commercialisation revolution

Nobel winner Sakaguchi hopes to harness regulatory T-cells against cancer

Clarivate Repeats Success in Nobel Prize Predictions with 6 New Laureates Identified by Citation Laureates Program

Trio win Nobel economics prize for work on innovation, growth and ‘creative destruction’

Nobel winners still pushing boundaries in Treg innovation

Dr. Michael McCullar, PhD – CEO, RegCell – Restoring Self Tolerance To The Immune System

Shifumi Sakaguchi’s company will conduct the first clinical trial of regulatory T cells

How T regs fueled a new class of immunology companies